{"product_id":"merit-bcg-matrix","title":"Merit Medical Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDownload Your Competitive Advantage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eWant a clear snapshot of Merit Medical’s product portfolio—what’s a Star, what’s bleeding cash, and what’s got potential? This preview just scratches the surface; buy the full BCG Matrix for quadrant-by-quadrant placements, data-backed recommendations, and a ready-to-use Word report plus an Excel summary. Get instant access and start reallocating capital with confidence—skip the research, use our strategic roadmap, and move faster. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRadial access and hemostasis portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRadial access and hemostasis portfolio sits in Stars as radial-first PCI rose to roughly 70% in Europe and about 60% in the US by 2024, keeping demand hot and driving consumable kit sales. Merit’s dedicated access kits and closure tools benefit from strong hospital preference and clinician familiarity, supporting share expansion. Continued investment in training and bedside placement can lock protocols and, with sustained market penetration, convert high growth into a textbook cash cow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEmbolotherapy for interventional oncology\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEmbolotherapy sits in the slipstream of fast-growing image-guided cancer care as procedure volumes and clinician demand for reliable embolics plus microcatheters rise; the embolization devices market was ~$2.3B in 2023 with ~6% CAGR anticipated to 2028. The model is capital-light but promotion-heavy—education, investigator-led trials and KOL programs drive uptake. Invest to broaden indications and secure formulary wins to capture share.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterventional radiology drainage and access kits\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eInterventional radiology drainage and access kits sit in Stars as IR volumes rise ~6% annually and the global IR devices market reached about $14B in 2024; bundled kits with dependable components win on speed and consistency in high-throughput labs. Market share is solid for Merit, with FY2024 revenue near $1.28B, but growth in ambulatory and community sites demands feet-on-the-ground support. Continued seeding of protocols and field training defends leadership and accelerates uptake.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCardiology pressure\/contrast management systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCardiology pressure\/contrast management systems remain mission-critical as cath lab throughput grows; Merit’s broad, compatible portfolio secures shelf space and drives steady adoption. Growth in 2024 stayed healthy but depends on ongoing conversions and operator training; maintain rep coverage and expand set standardization to accelerate share gains. Include targeted training programs and KOL-led demos to convert accounts.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket role: Stars\u003c\/li\u003e\n\u003cli\u003eStrategy: rep coverage + set standardization\u003c\/li\u003e\n\u003cli\u003eExecution: conversions, training, KOL demos\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOncology biopsy and localization accessories\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOncology biopsy and localization accessories are Stars as screening upticks and image-guided procedures boosted volumes; the global image-guided biopsy market reached about $3.2B in 2024 with ~7% CAGR. Workflow-simplifying kits see rapid adoption; maintaining share requires clinical evidence and high-touch service. Stay close to radiology departments to cement preference.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket size: $3.2B (2024)\u003c\/li\u003e\n\u003cli\u003eCAGR: ~7%\u003c\/li\u003e\n\u003cli\u003eDrivers: screening + image guidance\u003c\/li\u003e\n\u003cli\u003ePlaybook: evidence, service intensity, radiology engagement\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRadial PCI leadership plus IR, biopsy, embolics — invest in training and KOLs to win\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStars: radial access, embolotherapy, IR kits and oncology biopsy lead Merit’s high-growth portfolio—radial PCI ~70% Europe\/60% US (2024), IR devices ~$14B (2024), biopsy market ~$3.2B (2024); embolic market ~$2.3B (2023). Invest in training, KOLs, formulary wins to convert growth into durable share.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003e2024 Market\u003c\/th\u003e\n\u003cth\u003eCAGR\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRadial access\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIR devices\u003c\/td\u003e\n\u003ctd\u003e$14B\u003c\/td\u003e\n\u003ctd\u003e~6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiopsy\u003c\/td\u003e\n\u003ctd\u003e$3.2B\u003c\/td\u003e\n\u003ctd\u003e~7%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eIn-depth BCG Matrix review of Merit Medical’s products, outlining Stars, Cash Cows, Question Marks and Dogs with strategic actions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Merit Medical BCG Matrix that clarifies portfolio gaps and speeds strategic decisions\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHemostasis valves, stopcocks, and tubing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHemostasis valves, stopcocks, and tubing are mature, high-share disposables in Merit Medicals portfolio with dependable reorder cycles in 2024. They require low promotional lift and deliver steady margins. Process tweaks and sourcing wins flow directly to cash generation. Focus is on milking margins while defending against price-only challengers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAngio and inflation syringes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAngio and inflation syringes are staple SKUs in every cath lab with high turns and predictable demand, supporting Merit Medical’s cash-cow role after contributing to company revenues of $1.43 billion in 2024. Differentiation is modest but installed-use habits are sticky, keeping churn low and margins stable. Lean manufacturing and tight cost control drive ROI more than marketing; focus on optimizing contracts and keeping fill rates flawless to sustain cash flow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePressure transducers and critical care lines\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePressure transducers and critical care lines are entrenched standard of care products with stable protocols and minimal switching once embedded, delivering consistent volume across large IDNs; Merit Medical reported fiscal 2024 revenue of $1.09 billion, with these procedural staples acting as steady contributors. Investment emphasis is on quality and supply assurance to protect margins and uptime. These cash generators fund the next wave of product development and strategic growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBasic access needles, wires, and introducers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBasic access needles, wires, and introducers are commodity-leaning cash cows for Merit Medical: low single-digit market growth, steady replacement cycles, and scale-plus-reliability defend share; focus on operational efficiency over promotion, guard price, protect service levels, and harvest margins.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCommodity-leaning\u003c\/li\u003e\n\u003cli\u003eLow single-digit CAGR\u003c\/li\u003e\n\u003cli\u003eSteady replacement cycles\u003c\/li\u003e\n\u003cli\u003ePrioritize efficiency\u003c\/li\u003e\n\u003cli\u003eProtect price \u0026amp; service\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProcedure packs and kits for routine IR\/cardiology\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eProcedure packs and kits for routine IR\/cardiology moved Merit into accounts via customization and now deliver steady cash-flow through standardization; mature account relationships and auto-replenish programs lock volume, supporting Merit Medical’s scale (company revenue ≈ $1.06B in FY2024). Incremental engineering gains reduced unit costs and improved margins; maintain tight SKUs and contract terms to protect profitability.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCustomization-entry\u003c\/li\u003e\n\u003cli\u003eStandardization-retention\u003c\/li\u003e\n\u003cli\u003eAuto-replenish-volume\u003c\/li\u003e\n\u003cli\u003eEngineering-margin uplift\u003c\/li\u003e\n\u003cli\u003eSKU\/contract discipline\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMature disposables: steady margins, low promo, dependable reorders in 2024\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMature disposables (hemostasis valves, stopcocks, tubing) generate steady margins with low promo spend and reliable reorder cycles in 2024. Angio\/inflation syringes are cath-lab staples supporting Merit Medical’s cash-cow role; company revenue cited at $1.43B in 2024. Pressure transducers\/critical care lines and procedure kits deliver predictable volume; focus is on efficiency, supply assurance, and contract retention.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct Group\u003c\/th\u003e\n\u003cth\u003e2024 Fact\u003c\/th\u003e\n\u003cth\u003eMargin Driver\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHemostasis \u0026amp; disposables\u003c\/td\u003e\n\u003ctd\u003eReliable reorder\u003c\/td\u003e\n\u003ctd\u003eLow promo, sourcing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAngio\/inflation syringes\u003c\/td\u003e\n\u003ctd\u003eSupports $1.43B (2024)\u003c\/td\u003e\n\u003ctd\u003eHigh turns, stickiness\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePressure transducers\u003c\/td\u003e\n\u003ctd\u003eReported FY2024 $1.09B\u003c\/td\u003e\n\u003ctd\u003eQuality, uptime\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcedure packs\u003c\/td\u003e\n\u003ctd\u003eFY2024 ≈ $1.06B\u003c\/td\u003e\n\u003ctd\u003eAuto-replenish, SKU discipline\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Transparency, Always\u003c\/span\u003e\u003cbr\u003eMerit Medical BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing here is the exact Merit Medical BCG Matrix you'll receive after purchase. No watermarks, no placeholders—just the fully formatted, analysis-ready report designed for clarity. Once bought, the same document is yours to download, edit, print, or present immediately. Simple, professional, and built to slot straight into your strategy work.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56164155031929,"sku":"merit-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/merit-bcg-matrix.png?v=1762726311","url":"https:\/\/portersfiveforce.com\/products\/merit-bcg-matrix","provider":"Porter's Five Forces","version":"1.0","type":"link"}